A Clinical Study to Assess Preliminary Efficacy, Safety and Tolerability of HH-120 Nasal Spray in COVID-19 Patients
NCT05659602
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
111
Enrollment
OTHER
Sponsor class
Conditions
Coronavirus Disease 2019(COVID-19)
Interventions
BIOLOGICAL:
HH-120 Nasal Spray
Sponsor
Beijing Ditan Hospital